Characteristics | Number of patients (%) |
---|---|
Age (years) | |
Median (range) | 57 (39–75) |
Gender | |
Male/Female | 35 (76.1)/11 (23.9) |
ECOG a performance status | |
0-1 | 42 (91.3) |
2 | 4 (8.7) |
Pathology | |
Squamous-cell carcinoma | 28 (60.9) |
Adenocarcinoma | 14 (30.4) |
Other types | 4 (8.7) |
T staging after surgery b | |
T2/T3/T4 | 11 (23.9)/21 (45.7)/14 (30.4) |
N staging after surgery b | |
N0/N1/N2 | 10 (21.7)/22 (47.8)/14 (30.4) |
Tumor stage after surgery b | |
II | 11 (23.9) |
IIIa | 29 (63.0) |
IIIb | 6 (13.1) |
Follow-up time (months) | |
Median (range) | 40 (15.0-77.5) |